Overall, the mechanisms responsible for the protection against T1DM by oral vaccination with BLPs-IA-2ic may rely on immune deviation to a Th2 phenotype and induction of CD4+CD25+FoxP3+ Tregs. The gene discussed is CD4; the disease is type 1 diabetes mellitus.